CELYAD ONCOLOGY SA

CYAD
Real-time Quote. Real-time  - 09/24 11:03:16 am
3.7EUR -1.33%

Turn to zoom
Prev.3.7500
Open3.7500
High3.7500
Low3.6050
Volume10 191
Latest news
4d ago
09/08
09/01
09/01
Chart CELYAD ONCOLOGY SA
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance4,084,575,36
Spread/Res.-9,2%-19%-31%
Spread/Supp.5,6%5,6%5,4%
Support3,513,513,51
Financials
Sales 2021 4,32 M 5,06 M 5,06 M
Net income 2021 -29,8 M -34,9 M -34,9 M
Net Debt 2021 5,59 M 6,55 M 6,55 M
P/E ratio 2021 -1,91x
Yield 2021 -
Capitalization 58,4 M 68,4 M 68,5 M
EV / Sales 2021 14,8x
EV / Sales 2022 6,51x
Nbr of Employees 89
Free-Float 79,3%
Company
Celyad Oncology SA, formerly Celyad SA is a Belgium-based company. The Company is a clinical-stage biotechnology company focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company develops allogeneic and autologous CAR T cell therapy...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-11-10 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,75 €
Average target price 14,75 €
Spread / Average Target 293%